Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$319M |
| 2 |
GSK
GSK
|
+$230M |
| 3 |
LO
LORILLARD INC COM STK
LO
|
+$192M |
| 4 |
Verizon
VZ
|
+$174M |
| 5 |
Mastercard
MA
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$850M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$781M |
| 4 |
Bausch Health
BHC
|
+$466M |
| 5 |
Meta Platforms (Facebook)
META
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.58% |
| 2 | Technology | 5.48% |
| 3 | Financials | 4.9% |
| 4 | Energy | 3.61% |
| 5 | Consumer Discretionary | 3.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
Heartland Express
HTLD
$956M
| $38K | ﹤0.01% |
1,631
-2,784
| -63% | -$70.6K |
|
5302
PUT
Lindsay Corp
LNN
$1.18B
| $38K | ﹤0.01% |
500
-1,800
| -78% | -$151K |
|
5303
Omnicell
OMCL
$1.68B
| $38K | ﹤0.01% |
1,099
-986
| -47% | -$32.5K |
|
5304
Petrobras Class A
PBR.A
$103B
| $38K | ﹤0.01% |
6,408
-862
| -12% | -$5.61K |
|
|
PDS
5305
Precision Drilling
PDS
$974M
| $38K | ﹤0.01% |
319
-1,326
| -81% | -$152K |
|
5306
PUT
Ribbon Communications
RBBN
$383M
| $38K | ﹤0.01% |
5,400
+5,240
| +3,275% | +$86.3K |
|
|
NTUS
5307
DELISTED
Natus Medical Inc
NTUS
| $38K | ﹤0.01% |
966
-1,204
| -55% | -$44.4K |
|
|
FMBI
5308
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $38K | ﹤0.01% |
2,259
-3,855
| -63% | -$64.5K |
|
|
UNT
5309
CALL
DELISTED
UNIT Corporation
UNT
| $38K | ﹤0.01% |
+1,400
| New | +$41.6K |
|
|
APU
5310
PUT
DELISTED
AmeriGas Partners, L.P.
APU
| $38K | ﹤0.01% |
800
-200
| -20% | -$9.9K |
|
|
CYT
5311
CALL
DELISTED
CYTEC INDS INC
CYT
| $38K | ﹤0.01% |
700
-2,900
| -81% | -$145K |
|
|
EXXI
5312
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $38K | ﹤0.01% |
12,709
-5,082
| -29% | -$17.7K |
|
|
KKD
5313
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $38K | ﹤0.01% |
1,988
-3,323
| -63% | -$67.6K |
|
|
MNR
5314
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $38K | ﹤0.01% |
3,350
-10,626
| -76% | -$122K |
|
5315
AMC Entertainment Holdings
AMC
$2.31B
| $37K | ﹤0.01% |
108
-576
| -84% | -$180K |
|
5316
Chesapeake Utilities
CPK
$3.21B
| $37K | ﹤0.01% |
736
-1,492
| -67% | -$73.1K |
|
5317
Civeo
CVEO
$318M
| $37K | ﹤0.01% |
1,574
-6,905
| -81% | -$270K |
|
5318
EXL Service
EXLS
$5.29B
| $37K | ﹤0.01% |
4,890
-8,380
| -63% | -$54.9K |
|
5319
PUT
Ezcorp Inc
EZPW
$1.71B
| $37K | ﹤0.01% |
4,100
+3,700
| +925% | +$39.4K |
|
5320
Genpact
G
$5.76B
| $37K | ﹤0.01% |
1,600
| – | – |
|
5321
Hyatt Hotels
H
$16.7B
| $37K | ﹤0.01% |
626
+625
| +62,500% | +$36.5K |
|
5322
ICU Medical
ICUI
$4.61B
| $37K | ﹤0.01% |
402
-2,700
| -87% | -$236K |
|
5323
Mercado Libre
MELI
$92.3B
| $37K | ﹤0.01% |
300
-13,429
| -98% | -$1.7M |
|
5324
OneMain Financial
OMF
$7.47B
| $37K | ﹤0.01% |
734
-663
| -47% | -$26.7K |
|
5325
Ormat Technologies
ORA
$6.65B
| $37K | ﹤0.01% |
997
-3,703
| -79% | -$116K |
|
Similar funds
Barclays's Q1 2015 Portfolio in Review
As of Q1 2015, Barclays held 7,637 positions worth $86.7B, down 17% from $104B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays withdrew a net $19.4B in Q1 2015, closing 488 positions and reducing 4,377 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $781M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 5.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in iPath Pure Beta Broad Commodity ETN worth $55.8M.
- Barclays's largest Q1 2015 buy was iPath Pure Beta Broad Commodity ETN: 1,861,500 shares worth $55.8M.
- Barclays added most to Envision Healthcare Holdings Inc in Q1 2015, an estimated $319M increase.
- Barclays's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.08B.
- Barclays fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2015, selling an estimated $781M.
- Barclays's ten largest holdings make up 25% of its $86.7B portfolio in Q1 2015.
- Barclays opened 330 new positions and closed 488 in Q1 2015.
- Barclays's portfolio value fell 17% quarter-over-quarter to $86.7B.
Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.